For the third straight quarter in a row, OmniComm Systems, a leader in integrated electronic data capture solutions for clinical trials, is reporting another landmark quarter for new business. The company has surpassed its previous best quarter and signed contracts through the first two quarters of 2008 totaling almost $12 million, which surpass all of the revenues brought in from last year’s signed contracts.
During the second quarter, OmniComm signed a long-term guaranteed contract with a major biotechnology company which helped to boost the company’s financials. They have also continued to increase their customer base by adding seven new clients to their customer list, and continue to see recurring business from their existing loyal customers, who have added five more trials. Finally, they have added six new partners to their very successful Preferred Partnership Programs.
“I couldn’t be happier with the current momentum and speed in which we continue to grow,” said Stephen Johnson, COO of OmniComm. “We are extremely hot right now and I don’t see any signs of us slowing down. Our pipeline is stronger than ever and we are coming off one of our best trade shows to date at the recent DIA in Boston. We have grown from 47 to 83 people in the last year alone and we continue to hire industry experienced individuals, something that I think that is lacking in other EDC companies. Our recipe for success is simple — we offer the best products and services at the best price and we smother our customers with close, personal attention.”
The contracts and breakdown of new business for the second quarter of 2008 will call for OmniComm Systems to provide Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life-changing clinical trial research.
Let us hear your thoughts below: